Contract 75N93022C00003
Rho Federal Systems Division Inc · Department Of Health And Human Services · January 25, 2022
Rho Federal Systems Division Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on January 25, 2022 for $40.13 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Durham, NC. It was awarded under full and open competition. The contract has been modified 11 times since the base award It uses cost-plus contract pricing. The most recent modification was on January 30, 2026.
Contract details
- PIID
- 75N93022C00003
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Durham, NC
- First action
- January 25, 2022
- Latest action
- January 30, 2026
Description
AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
Modification timeline
-
January 30, 2026Mod P00011$0
-
January 29, 2026Mod P00010$8.00M
-
July 29, 2025Mod P00009$3.00M
-
January 31, 2025Mod P00008$5.00M
-
August 1, 2024Mod P00007$3.01M
-
January 11, 2024Mod P00006$5.00M
-
January 4, 2024Mod P00005$290.4K
-
November 28, 2023Mod P00004$0
-
August 16, 2023Mod P00003$2.52M
-
January 19, 2023Mod P00002$5.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93022C00003?
Contract 75N93022C00003 is a federal contract awarded to Rho Federal Systems Division Inc by Department Of Health And Human Services on January 25, 2022 for $40.13 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 11 times since the base award.
Who won contract 75N93022C00003?
Rho Federal Systems Division Inc won contract 75N93022C00003 from Department Of Health And Human Services.
How much is contract 75N93022C00003 worth?
Contract 75N93022C00003 has obligated $40.13 million to date.